DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Treatment of Geriatric Bipolar Mood Disorders: A Pilot Study

Information source: University of Pittsburgh
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Bipolar Disorder

Intervention: lithium carbonate (Drug); Depakote-ER (Drug); risperidone (Drug); olanzapine (Drug); paroxetine (Drug); bupropion (Drug); lamotrigine (Drug); venlafaxine (Drug); tranylcypromine (Drug); mirtazapine (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: University of Pittsburgh

Official(s) and/or principal investigator(s):
Charles F Reynolds III, MD, Principal Investigator, Affiliation: University of Pittsburgh

Summary

The purpose of this study is to collect pilot data on the feasibility of recruiting, eliciting informed consent, assessing, treating, and following patients aged 60 and older with bipolar mood disorders.

Clinical Details

Official title: Treatment of Geriatric Bipolar Mood Disorders: A Pilot Study

Study design: Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome: The percent of subjects remitting from their index affective episode, the time to remission, the percent of partially and non-remitting patients, the incidence of relapse during continuation treatment, and of recurrence during maintenance treatment

Secondary outcome: Measures of affective symptoms, functional status, side effects, and cognition tracked over acute, continuation, and maintenance phases of treatment.

Detailed description: Study specific aims are:

- to establish a recruitment, referral, and collaborative network for elderly bipolar

patients, in collaboration with the NIMH funded STEP-BD

- to establish an outpatient treatment clinic at the Bellefield Towers site of the NIMH

funded Intervention Research Center for Late Life Mood Disorders

- to implement standardized care pathways compatible with STEP-BD treatment algorithms

for mood stabilizing pharmacotherapy.

- to document short- and long-term treatment response with respect to affective symptoms,

sleep, general life functioning, cognition, treatment-emergent side effects

- to establish the clinical infrastructure necessary for randomized controlled clinical

trials and for clinical research training in bipolar mood disorders of late-life.

Eligibility

Minimum age: 60 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- DSM-IV diagnosis of Bipolar Disorder

- Folstein Mini-Mental Status Exam score of 18 or higher

Exclusion Criteria:

- Medical condition that precludes the use of both lithium and depakote

- If mood disturbance is deemed an organic mood disorder (i. e., iatrogenic, secondary

to medication)

- If refuse to designate someone who the study staff can contact about bipolar

symptoms, concerns about the subject's health, in an emergency, and/or inability to reach the subject.

Locations and Contacts

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, United States

University of Pittsubrgh Medical Center, Pittsburgh, Pennsylvania 15213, United States

Additional Information

An online resource for older individuals with mental health needs

Starting date: July 2001
Last updated: September 13, 2005

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017